RenovaCare, Inc. (RCAR)
| Market Cap | 87.00 |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -5.74M |
| Shares Out | 87.35M |
| EPS (ttm) | -0.07 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 3,335 |
| Average Volume | 2,417 |
| Open | 0.0002 |
| Previous Close | 0.0001 |
| Day's Range | 0.0001 - 0.0002 |
| 52-Week Range | 0.0000 - 0.0010 |
| Beta | -96.90 |
| RSI | 46.95 |
| Earnings Date | n/a |
About RenovaCare
RenovaCare, Inc., a development-stage biotech and medical device company, focuses on the research, development, and commercialization of autologous cellular therapies for use in medical and aesthetic applications. It is developing CellMist System, a treatment methodology for cell isolation for the regeneration of human skin cells; and SkinGun, a solution sprayer device for delivering the cells to the treatment area. RenovaCare, Inc. has a strategic collaboration StemCell Systems GmbH for isolating and spraying self-donated stem cells to regener... [Read more]
Financial Performance
News
RenovaCare Inc. Provides Notice of Proposed Derivative Settlement to All Record Holders and Beneficial Owners of RenovaCare, Inc.
SCOTTSDALE, Ariz.--(BUSINESS WIRE)--RenovaCare Inc. (OTC: RCAR): IN THE EIGHTH JUDICIAL DISTRICT COURT OF THE STATE OF NEVADA IN AND FOR CLARK COUNTY PETER RIGSBY, Derivatively on Behalf of RENOVACARE...
RenovaCare Announces Termination of StemCell Systems R&D Agreement
SCOTTSDALE, Ariz., May 03, 2022 (GLOBE NEWSWIRE) -- RenovaCare, Inc. (Symbol: RCAR; www.renovacareinc.com), a clinical-stage developer of patented technologies for isolating and spraying cells for the...
RenovaCare Announces Management Changes
SCOTTSDALE, Ariz., March 24, 2022 (GLOBE NEWSWIRE) -- RenovaCare, Inc. (Symbol: RCAR; www.renovacareinc.com), a clinical-stage developer of patented technologies for isolating and spraying cells for t...
RenovaCare Provides Clinical and Corporate Update
SCOTTSDALE, Ariz., March 09, 2022 (GLOBE NEWSWIRE) -- RenovaCare, Inc. (Symbol: RCAR; www.renovacareinc.com), a clinical-stage developer of patented technologies for isolating and spraying cells for t...
RM LAW Announces Investigation of RenovaCare, Inc.
BERWYN, Pa. , Feb. 3, 2022 /PRNewswire/ -- RM LAW, P.C.
RenovaCare Update
Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In RenovaCare To Contact Him Directly To Discuss Their OptionsNew York, New York--(Newsfile...
BREAKING NEWS: TOP RANKED ROSEN LAW FIRM Encourages RenovaCare, Inc. Investors with Losses Over $100K to Secure Counsel Before Important Deadline - RCAR
NEW YORK, July 19, 2021 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of RenovaCare, ...
RCAR INVESTOR NOTICE: Rosen Law Firm Encourages RenovaCare, Inc. Investors with Losses to Secure Counsel Before Important Deadline – RCAR
NEW YORK--(BUSINESS WIRE)--WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of RenovaCare, Inc. (OTC: RC...
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of RenovaCare, Inc. (RCAR) on Behalf of Investors
LOS ANGELES--(BUSINESS WIRE)---- $RCAR #CLASSACTION--Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm, today announced that it has commenced an investigation on beha...
The Law Offices of Frank R. Cruz Announces Investigation of RenovaCare, Inc. (RCAR) on Behalf of Investors
LOS ANGELES--(BUSINESS WIRE)---- $RCAR #investors--The Law Offices of Frank R. Cruz Announces Investigation of RenovaCare, Inc. (RCAR) on Behalf of Investors
RenovaCare Clinical Trial to Start at U.S. Burn Centers
ROSELAND, N.J., June 07, 2021 (GLOBE NEWSWIRE) -- RenovaCare, Inc. (Symbol: RCAR; www.renovacareinc.com), today announced that it is initiating a clinical trial at four burn centers in the United Stat...
RenovaCare Responds to SEC Complaint
ROSELAND, N.J., June 01, 2021 (GLOBE NEWSWIRE) -- RenovaCare, Inc. (Symbol: RCAR; www.renovacareinc.com) today announced that it intends to vigorously defend itself and its stockholders against allega...
RenovaCare Announces Organizational Changes and Appointment of New Officers
ROSELAND, N.J., March 30, 2021 (GLOBE NEWSWIRE) -- RenovaCare, Inc. (Symbol: RCAR; www.renovacareinc.com), developer of patented technologies for spraying self-donated stem cells for the regeneration ...
RenovaCare to Present at H.C. Wainwright Global Life Sciences Conference March 9-10, 2021
ROSELAND, N.J., Feb. 25, 2021 (GLOBE NEWSWIRE) -- RenovaCare, Inc. (Symbol: RCAR; www.renovacareinc.com), a clinical-stage developer of patented technologies for spraying self-donated stem cells for t...
RenovaCare to Present at Noble Capital Markets Annual Investor Conference on January 19, 2021
ROSELAND, N.J., Jan. 19, 2021 (GLOBE NEWSWIRE) -- RenovaCare, Inc. (Symbol: RCAR; www.renovacareinc.com), a clinical-stage developer of patented technologies for spraying self-donated stem cells for...
RenovaCare to Present at H.C. Wainwright BioConnect 2021 Conference
ROSELAND, N.J., Jan. 08, 2021 (GLOBE NEWSWIRE) -- RenovaCare, Inc. (Symbol: RCAR; www.renovacareinc.com), a clinical-stage developer of patented technologies for spraying self-donated stem cells for t...